Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/22/2012CA2835599A1 Osteogenesis promoter
11/22/2012CA2835496A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
11/22/2012CA2835428A1 Engineered nucleic acids and methods of use thereof for non-human vertebrates
11/22/2012CA2835336A1 Pharmaceutical combination for use in the treatment of diabetes type 2 patients
11/22/2012CA2835265A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
11/22/2012CA2835259A1 Lixisenatide and metformin for treatment of diabetes type 2
11/22/2012CA2834182A1 Honey composition with l-alanyl-l-glutamine
11/22/2012CA2833515A1 High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain
11/21/2012EP2524700A1 Mucinous glycoprotein (muc-1) vaccine
11/21/2012EP2524698A1 Insulin preparation
11/21/2012EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment
11/21/2012EP2523968A1 Cyclic peptides for the regulation of vectorial ion channels
11/21/2012EP2523730A1 Methods of treating glucose metabolism disorders
11/21/2012EP2523712A1 Preservative free insulin formulations and systems and methods for aerosolizing
11/21/2012EP2523680A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma
11/21/2012EP2523679A2 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
11/21/2012EP2523678A2 Wnt antagonists and methods of treatment and screening
11/21/2012EP2523677A2 Method for treatment of inflammatory disease and disorder
11/21/2012EP2523668A1 Treatment of multiple sclerosis
11/21/2012EP2523655A2 Pharmaceutical compositions for oral administration of insulin peptides
11/21/2012EP2523653A2 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
11/21/2012EP2523553A1 Methods and compositions for treating bleeding disorders
11/21/2012CN102791856A Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
11/21/2012CN102791736A Antagonists of Dsg2 for treatment of cancer
11/21/2012CN102791731A GLP-1 analogues and derivatives
11/21/2012CN102791295A Nucleic acid complexes
11/21/2012CN102791292A Delivery system for diagnostic and therapeutic agents
11/21/2012CN102791290A A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy
11/21/2012CN102791285A Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
11/21/2012CN102791284A Method of treatment or prevention of hair loss or for the enhancement of hair growth
11/21/2012CN102791283A Use of transforming growth factor-beta 1 (TGF-beta 1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
11/21/2012CN102791282A Orally administerable pharmaceutical preparation containing insulin
11/21/2012CN102791281A Peptide protection against ultraviolet light toxicity
11/21/2012CN102791280A Methods for the prevention or treatment of vessel occlusion injury
11/21/2012CN102791279A Methods for performing a coronary artery bypass graft procedure
11/21/2012CN102791278A Cell protectants comprising placenta extracts
11/21/2012CN102791134A Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
11/21/2012CN102787131A Solen grandis chymotrypsin gene SgChy and recombinant protein of solen grandis chymotrypsin gene SgChy
11/21/2012CN102787119A Products and methods for treatment and/or prevention of virus infections
11/21/2012CN102787109A Methoxy polyethylene glycol-lumbrukinase conjugate and its preparation method
11/21/2012CN102787102A Porcine alpha interferon mature-protein recombinant adenovirus, construction method and application thereof
11/21/2012CN102786590A Branching-type PEG-modified GLP-1 analogs and pharmaceutically acceptable salts thereof
11/21/2012CN102786583A Rana kunyuensis kunyuenin kunyuenin-3 as well as preparation method and application of rana kunyuensis kunyuenin kunyuenin-3
11/21/2012CN102786580A Antihypertensive active peptide IVP
11/21/2012CN102786579A Antihypertensive active peptide VIP
11/21/2012CN102784396A Use of antioxidants for gene modulation
11/21/2012CN102784391A IL-23 and its receptor
11/21/2012CN102784388A Nutrient health care product for reducing trioxypurine
11/21/2012CN102784387A Modified mutant collagenase and it's use in fat melting and in scar reduction
11/21/2012CN102784386A Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
11/21/2012CN102784385A Peptide selection method
11/21/2012CN102784384A Application of combination of low-dose naltrexone and methionine-enkephalin to preparation of anti-cancer drug
11/21/2012CN102784383A Methods for preventing mitochondrial permeability transition
11/21/2012CN102784382A Argatroban drug composition and preparation method and application of argatroban drug composition
11/21/2012CN102784381A Clinical scientific prescription for treating cataract
11/21/2012CN102784264A Anticancer preparation
11/21/2012CN102784171A Preparation method of freeze-drying activated bionic honeycomb pollen and preparation thereof
11/21/2012CN102784114A Bortezomib freeze-dried powder injection and preparation method thereof
11/21/2012CN102784112A Preparation method for porous slow-release microsphere of chitosan graft copolymer
11/21/2012CN102784106A Oral calcitonin liposome and lyophilized preparation thereof
11/21/2012CN102416166B Aerosol inhalant containing interferon alpha and ipratropium bromide
11/21/2012CN102268422B Cordyceps sobolifera protease capable of inhibiting human immunodeficiency virus-1 (HIV-1) reverse transcriptase and preparation method for Cordyceps sobolifera protease
11/21/2012CN102258708B Health-preserving wine and preparation method thereof
11/21/2012CN102228684B Chinese medicinal composition for enhancing immunity of children and application thereof
11/21/2012CN102181450B Trichina Ts27 gene, encoding protein and application thereof
11/21/2012CN102154418B Preparation method of animal interferon
11/21/2012CN102068700B Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material
11/21/2012CN102060910B HLA (Human Leukocyte Antigen)-A*0201 limitation CTL (Cytotoxic T Lymphocyte) epitope of zinc translocator and application thereof
11/21/2012CN102030829B Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof
11/21/2012CN102030819B Broad spectrum polypeptin and application thereof
11/21/2012CN102030817B Peptide for inhibiting angiontensin converting enzyme
11/21/2012CN101921314B Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease and preparation method
11/21/2012CN101920004B Preparation and application of coconut globulin ferrous complex iron supplement agent
11/21/2012CN101909599B Counter-pressure filtration of proteins
11/21/2012CN101775067B New synthesized antibacterial peptide as well as preparation method and application thereof
11/21/2012CN101768219B Recombinant fusion protein and preparing method and application thereof
11/21/2012CN101683518B Application of FHL 1 in preparing medicament for treating tumour
11/21/2012CN101664378B Medical composition of recombinant human serum albumin and interferon alpha fusion protein
11/21/2012CN101423550B Genetic engineering immunosuppressive polypeptide and preparation method and application
11/21/2012CN101273128B Platelet aggregation inhibitor composition
11/21/2012CN101272803B Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink
11/21/2012CN101189258B A peptide ligand to impair cancer cell migration
11/20/2012US8314217 Cross-linked glycopeptide-cephalosporin antibiotics
11/20/2012US8314211 Tissue sealant for use in non compressible hemorrhage
11/20/2012US8314210 Compositions and methods for the generation of MHC class II compounds by peptide exchange
11/20/2012US8314208 Microwave enhanced N-fmoc deprotection in peptide synthesis
11/20/2012US8314141 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8314066 GH secretagogues and uses thereof
11/20/2012US8314065 Method of reduction of wrinkles on skin or acceleration of wound healing by applying peptides related to basic fibroblast growth factor (bFGF)
11/20/2012US8314064 Administering choline cytidine 5-pyrophosphate which raises levels of uridine or uridine phosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease
11/20/2012US8314063 Pharmaceutical formulations
11/20/2012US8314062 Macrocyclic compounds as antiviral agents
11/20/2012US8314060 Peptide conjugated anti-cancer prodrugs
11/20/2012US8314059 Diabetic nephropathy therapies
11/20/2012US8314058 Uptake of macromolecules
11/20/2012US8313950 Hepcidins as biomarkers for impending lupus nephritis flare
11/20/2012US8313928 Expression system
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 3163